郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

肿瘤模型A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models.

期刊：The journal of pain发表年份：2020作者：Wei Lei; Rakesh H Vekariya; Subramaniam Ananthan; John M Streicher
阅读更多 →

肿瘤模型BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine.

期刊：Neuropharmacology发表年份：2020作者：Po-Kuan Chao; Hsiao-Fu Chang; Wan-Ting Chang; Teng-Kuang Yeh; Li-Chin Ou; Jian-Ying Chuang; John Tsu-An Hsu; Pao-Luh Tao; Horace H Loh; Chuan Shih; Shau-Hua Ueng; Shiu-Hwa Yeh
阅读更多 →

肿瘤模型A small-sized protein binder specific for human PD-1 effectively suppresses the tumour growth in tumour mouse model.

期刊：Journal of drug targeting发表年份：2020作者：Sumin Son; Jinho Park; Hyodeok Seo; Hyun Tae Lee; Yong-Seok Heo; Hak-Sung Kim
阅读更多 →

肿瘤模型SPA: a peptide antagonist that acts as a cell-penetrating peptide for drug delivery.

期刊：Drug delivery发表年份：2020作者：Jingjing Song; Sujie Huang; Zhengzheng Zhang; Bo Jia; Huan Xie; Ming Kai; Wei Zhang
阅读更多 →